Skip to main content

Advertisement

Log in

Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

The effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) administered separately or with anthelmintic albendazole (ABZ) on cellular immunity of mice with alveolar echinococcosis was studied. The proliferative activity of splenic T and B lymphocytes was the most stimulated after combined L-MTP-PE + ABZ therapy [from weeks 8 to 14 post-infection (p.i.)] that also induced a long-term development of protective Th1 response (the highest serum concentration of IFN-γ from weeks 8 to 18 p.i.). On the contrary, Th2 response (cytokine IL-5) in infected mice treated with L-MTP-PE was inhibited since week 8 p.i., but a significant long-term decrease in IL-5 concentration was found after combined L-MTP-PE + ABZ therapy until the end of the experiment (until week 26 p.i.). L-MTP-PE stimulated the production of superoxide anion (O2 ) by peritoneal macrophages from weeks 8 to 12 p.i., but the highest O2 production was accordingly recorded after therapy L-MTP-PE + ABZ from weeks 8 to 18 p.i. Stimulation of cellular immunity of mice with alveolar echinococcis with L-MTP-PE and an interaction with ABZ’s anti-parasitic effect resulted in the greatest and long-term reduction of growth of Echinococcus multilocularis cysts in the host from week 10 p.i. until the end of the experiment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Adam A, Lederer E (1988) Muramylpeptides as immunomodulators. Immunology 1:205–214

    CAS  Google Scholar 

  • Adinolfi LE, Bonventre PF, Vanderpas M, Eppstein DA (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral Leishmaniasis. Infect Immun 48:409–416

    PubMed  CAS  Google Scholar 

  • Altintas N, Orenay S, Reyhan E, Turk M, Asci M, Turel S, Yolasigmaz A, Altintas N (2007) Genotoxic effects of albendazole in patients medicated for cystic echinococcosis. Helminthologia 44:57–61

    Article  CAS  Google Scholar 

  • Antolová D, Miterpáková M, Reiterová K, Dubinský P (2006) Influence of anthelmintic baits on the occurrence of causative agents of helminthozoonoses in red foxes (Vulpes vulpes). Helminthologia 43:226–231

    Article  Google Scholar 

  • Asano T, McWatters A, An T, Matsushima K, Kleinerman ES (1994) Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. J Pharmacol Exp Ther 268:1032–1039

    PubMed  CAS  Google Scholar 

  • Capece BPS, Navarro M, Arcalis T, Castells G, Toribio L, Perez F, Carretero A, Ruberte J, Arboix M, Cristofol C (2003) Albendazole sulphoxide enantiomers in pregnant rats embryo concentrations and developmental toxicity. Vet J 165:266–275

    Article  PubMed  CAS  Google Scholar 

  • Dieter P, Ambs P, Fityke E, Schwende H (1997) Lipopolysaccharide and liposome-encapsulated MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor-alpha and nitric oxide in liver macrophages. Adv Exp Med Biol 407:485–490

    PubMed  CAS  Google Scholar 

  • Dieter P, Hempel U, Malessa B, Fitzke E, Tran-Thi TA, MacLouf J, Creminon C, Kanaoka Y, Urade Y (1999) Lipopolysaccharide- and liposome-encapsulated MTP-PE-induced formation of eicosanoids, nitric oxide and tumor necrosis factor-alpha in macrophages. Adv Exp Med Biol 469:443–448

    PubMed  CAS  Google Scholar 

  • Dvorožňáková E, Borošková Z, Dubinský P, Tomašovičová O, Hříbalová V, Machnicka B (1999) Immunomodulative effect of muramyldipeptide in mice with larval toxocarosis. Parasitol Res 85:1034–1040

    Article  PubMed  Google Scholar 

  • El-On J (2003) Benzimidazole treatment of cystic echinococcosis. Acta Trop 85:243–252

    Article  PubMed  CAS  Google Scholar 

  • Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C (1996) Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 18:463–472

    Article  PubMed  CAS  Google Scholar 

  • Fiorentino D, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444–3451

    PubMed  CAS  Google Scholar 

  • Gay B, Cardot JM, Schnell C, van Hoogevest P, Gygax D (1993) Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE. J Pharm Sci–US 82:997–1001

    Article  CAS  Google Scholar 

  • Gottstein B, Wunderlin E, Tanner I (1994) Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or ‘resistant’ (C57B1/10) to secondary alveolar echinococcosis. Clin Exp Immunol 96:245–252

    PubMed  CAS  Google Scholar 

  • Gottstein B, Haag K, Walker M, Matsumoto J, Mejri A, Hemphill A (2006) Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 55:S45–S49

    Article  PubMed  CAS  Google Scholar 

  • Graichen DAS, Gottstein B, Matsumoto J, Müller N, Zanotto PMA, Ayala FJ, Haag KL (2007) Expression and diversity of Echinococcus multilocularis AgB genes in secondarily infected mice: evaluating the influence of T-cell immune selection on antigenic variation. Gene 392:98–105

    Article  PubMed  CAS  Google Scholar 

  • Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA (2003) Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop 85:231–236

    Article  PubMed  CAS  Google Scholar 

  • Hrčková G, Velebný S (1997) Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology 114:475–482

    Article  PubMed  Google Scholar 

  • Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547–549

    Article  PubMed  CAS  Google Scholar 

  • Hübner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, Kern P, Soboslay PT (2006) Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol 145:243–251

    Article  PubMed  CAS  Google Scholar 

  • Hui GS, Tam LQ, Chang SP, Case SE, Hashiro C, Siddiqui WA, Shiba T, Kusumoto S, Kotani S (1991) Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Infect Immun 59:1585–1591

    PubMed  CAS  Google Scholar 

  • Jenne L, Kilwinski J, Scheffold W, Kern P (1997) IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin Exp Immunol 109:90–97

    Article  PubMed  CAS  Google Scholar 

  • Karpoff HM, Jarnagin W, Delman K, Fong Y (2000) Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance. Surgery 128:213–218

    Article  PubMed  CAS  Google Scholar 

  • Kern P (2006) Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Parasitol Int 55:S273–S282

    Article  PubMed  Google Scholar 

  • Kinčeková J, Hrčková G, Auer H, Szilágyiová M, Hudáčková J, Stanislayová M, Poláček H, Šimeková K (2006) Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy. Helminthologia 43:213–219

    Article  Google Scholar 

  • Kizaki T, Kobayashi S, Ogasawara K, Day NK, Good RA, Onoe K (1991) Immune suppression induced by protoscoleces of Echinococcus multilocularis in mice. Evidence for the presence of CD8dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J Immunol 147:1659–1666

    PubMed  CAS  Google Scholar 

  • Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA (1998) Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 5:231–237

    PubMed  CAS  Google Scholar 

  • Manfras BJ, Reuter S, Wendland T, Kern P (2002) Increased activation and oligoclonality of peripheral CD8+ T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun 70:1168–1174

    Article  PubMed  CAS  Google Scholar 

  • Manfras BJ, Reuter S, Wendland T, Boehm BO, Kern P (2004) Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 16:43–50

    Article  PubMed  CAS  Google Scholar 

  • Melissen PM, van Vianen W, Leenen PJ, Bakker-Woundenberg IA (1993a) Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPE. Biotherapy 7:71–78

    Article  PubMed  CAS  Google Scholar 

  • Melissen PM, van Vianen W, Bidjai O, van Marion M, Bakker-Woundenberg IA (1993b) Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-g (IFN-g) in experimental infection with Listeria monocytogenes. Biotherapy 6:113–124

    Article  PubMed  CAS  Google Scholar 

  • Miterpáková M, Antolová D, Šefčíková Z, Stanko M, Dinkel A, Gašpar Š, Dubinský P (2006a) Echinococcus multilocularis in musk rat (Ondatra zibethicus): the first finding of the parasite in naturally infected rodent in the Slovak Republic. Helminthologia 43:76–80

    Article  Google Scholar 

  • Miterpáková M, Dubinský P, Reiterová K, Stanko M (2006b) Climate and environmental factors influencing Echinococcus multilocularis occurrence in the Slovak Republic. Ann Agric Environ Med 13:235–242

    PubMed  Google Scholar 

  • Pabst MJ, Beranova-Giorgianni S, Krueger JM (1999) Effects of muramyl peptides on macrophages, monokines, and sleep. Neuroimmunomodulation 6:261–283

    Article  PubMed  CAS  Google Scholar 

  • Pagé M, Bajaouni N, Ciqo-Mars B, Lemieux P (1988) Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int J Immunopharmacol 10:785–793

    Article  PubMed  Google Scholar 

  • Porubcová J, Dvorožňáková E, Ševčíková Z (2007a) Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis. Parasitol Res 101:751–760

    Article  PubMed  Google Scholar 

  • Porubcová J, Dvorožňáková E, Ševčíková Z (2007b) Immune response of mice to Echinococcus multilocularis infection after therapy with amphotericin B colloidal dispersion. Helminthologia 44:47–56

    Article  CAS  Google Scholar 

  • Reimann J, Kaufmann SHE (1997) Alternative antigen processing pathways in anti-effective immunity. Curr Opin Immunol 9:462–469

    Article  PubMed  CAS  Google Scholar 

  • Reiterová K, Miterpáková M, Turčeková L, Antolová D, Dubinský P (2005) Field evaluation of an intravital diagnostic test of Echinococcus multilocularis infection in red foxes. Vet Parasitol 128:65–71

    Article  PubMed  Google Scholar 

  • Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P (2000) Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 46:451–456

    Article  PubMed  CAS  Google Scholar 

  • Sehra S, Chugh L, Gangal SV (1998) Role of liposomes in selective proliferation of splenic lymphocytes. Mol Cell Biochem 183:133–139

    Article  PubMed  CAS  Google Scholar 

  • Sher A, Fiorentino D, Caspar P, Pearce E, Mosmann T (1991) Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol 147:2713–2716

    PubMed  CAS  Google Scholar 

  • Šnábel V, Miterpáková M, D’Amelio S, Busi M, Bartková D, Turčeková L, Maddox-Hyttel C, Skuce P, Dubinský P (2006) Genetic structuring and differentiation of Echinococcus multilocularis in Slovakia assessed by sequencing and isoenzyme studies. Helminthologia 43:196–202

    Article  Google Scholar 

  • Šoltýs J, Quinn MT (1999) Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect Immun 67:244–252

    PubMed  Google Scholar 

  • Šoltýs J, Turčeková L, de Rycke PH (1999) The effect Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia 36:25–30

    Google Scholar 

  • Souvannavong V, Brown S, Adam A (1988) The synthetic immunomodulator muramyl dipeptide (MDP) can stimulate activated B cells. Mol Immunol 25:385–391

    Article  PubMed  CAS  Google Scholar 

  • Sturm D, Menzel J, Gottstein B, Kern P (1995) Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 63:1688–1697

    PubMed  CAS  Google Scholar 

  • Tanguay S, Bucana CD, Wilson MR, Fidler IJ, von Eschenbach AC, Killion JJ (1994) In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A. Cancer Res 5:5882–5888

    Google Scholar 

  • ten Hagen TL, van Vianen W, Savelkoul HF, Heremans H, Buurman WA, Bakker-Woundenberg IA (1998) Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. Infect Immun 66:1962–1967

    PubMed  CAS  Google Scholar 

  • Vuitton DA (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85:119–132

    Article  PubMed  CAS  Google Scholar 

  • Vuitton DA (2004) Echinococcosis and allergy. Clin Rev Allergy Immunol 26:93–104

    Article  PubMed  Google Scholar 

  • Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S (2006) Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 55:S51–S55

    Article  PubMed  CAS  Google Scholar 

  • Xu Z, Fidler IJ (1984) The in situ activation of cytotoxic properties in murine Kupffer cells by the systemic administration of whole Mycobacterium bovis organisms or muramyl tripeptide. Cancer Immunol Immunother 18:118–122

    Article  PubMed  CAS  Google Scholar 

  • Zhang W, McManus DP (2006) Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 47:2441

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Slovak Research and Development Agency under the contract No. APVV-51-027605, the Slovak-Italian Science and Technology Cooperation for 2004–2007 (project “08 TAL”) and by the Slovak VEGA agency, grant No. 2/7186/27. The experimental protocols complied with the current Slovak ethic law.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emília Dvorožňáková.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dvorožňáková, E., Porubcová, J., Šnábel, V. et al. Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole. Parasitol Res 103, 919–929 (2008). https://doi.org/10.1007/s00436-008-1077-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-008-1077-2

Keywords

Navigation